FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss

被引：2
|
作者：
Carvalho, Thiago
机构：
来源：
NATURE MEDICINE | 2023年 / 29卷 / 09期
关键词：
D O I：
10.1038/d41591-023-00065-z
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Nature Medicine explores the latest translational and clinical research news, with a newly approved JAK and TEC inhibitor for the autoimmune disease alopecia areata.
引用
收藏
页码：2144 / 2145
页数：2
相关论文
共 50 条
  • [41] CarbocisteineToxic epidermal necrolysis and alopecia areata-like hair loss: case report
    Reactions Weekly, 2018, 1730 (1) : 84 - 84
  • [42] Racial Disparities in Hair Loss Episodes in Patients with Alopecia Areata: A Retrospective Cohort Study
    Chen, Li-Chi
    Baranwal, Navya
    Lim, Rachel K.
    Zhang, Helen
    Qureshi, Abrar A.
    Cho, Eunyoung
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (11)
  • [43] Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (Alopecia Areata)
    Siebenhaar, Frank
    Sharov, Andrey A.
    Peters, Eva M. J.
    Sharova, Tatyana Y.
    Syska, Wolfgang
    Mardaryev, Andrei N.
    Freyschmidt-Paul, Pia
    Sundberg, John P.
    Maurer, Marcus
    Botchkarev, Vladimir A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (06) : 1489 - 1497
  • [44] Jak inhibitor intraclass switch in Alopecia Areata patients: a retrospective review of cases at an academic center
    Silva, Isabel
    Khattri, Saakshi
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [45] Coexistence of giant blue nevus of the scalp with hair loss and alopecia areata Poster Session
    Takeichi, S.
    Kubo, Y.
    Hirose, K.
    Arase, S.
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (06) : 610 - 610
  • [46] Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
    Matteini, Enrico
    Diluvio, Laura
    Lambiase, Sara
    Cioni, Arnaldo
    Shumak, Ruslana Gaeta
    Costanza, Gaetana
    Lanna, Caterina
    Caldarola, Giacomo
    Bianchi, Luca
    Campione, Elena
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17 : 2225 - 2230
  • [47] Which is the ideal JAK inhibitor for alopecia areata - Baricitinib, tofacitinib, ritlecitinib or ifidancitinib-Revisiting the immunomechanisms of the JAK pathway
    Sardana, Kabir
    Bathula, Savitha
    Khurana, Ananta
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2023, 14 (04) : 465 - 474
  • [48] Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
    Nunez, Mariela
    Kar, Supratik
    Rodriguez, Katherine A.
    Ondieki, Dariel
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (11-12) : 1023 - 1036
  • [49] Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia
    Frewen, John
    Alsaadi, Dalia
    Asfour, Leila
    Belmo, Sharon
    Bryden, Alyson
    Champagne, Caroline
    Clayton, Nicola
    Cooke, Nicola
    Cummins, Donna M.
    Fairhurst, David
    Farrant, Paul
    Hale, Gordan
    Holmes, Susan
    Harries, Thomas
    Jones, Ruth
    Karanovic, Sanja
    Kaur, Manjit R.
    Meah, Nekma
    Mowbray, Megan
    Rao, Archana
    Rouhani, Nasim
    Salmon, Nicola
    Takwale, Anita
    Wade, Martin
    Wong, Sharon
    Zaheri, Shirin
    Al-Nuaimi, Yusur
    Harries, Matthew
    JEADV CLINICAL PRACTICE, 2025, 4 (01): : 72 - 81
  • [50] Establishing and prioritizing research questions for the prevention, diagnosis and treatment of hair loss (excluding alopecia areata): the Hair Loss Priority Setting Partnership
    Macbeth, A.
    Tomlinson, J.
    Messenger, A.
    Moore-Millar, K.
    Michaelides, C.
    Shipman, A.
    Kassim, J.
    Brockley, J.
    Szczecinska, W.
    Farrant, P.
    Robinson, R.
    Rodgers, J.
    Chambers, J.
    Upadhyaya, S.
    Harries, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (02) : 535 - 540
12345